Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,237 | 403 | 96.8% |
| Gift | $126.05 | 5 | 1.7% |
| Education | $113.71 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,818 | 91 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,562 | 129 | $0 (2024) |
| Gilead Sciences, Inc. | $375.91 | 22 | $0 (2024) |
| Celgene Corporation | $343.52 | 32 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $332.86 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $287.78 | 9 | $0 (2024) |
| Braintree Laboratories, Inc. | $259.35 | 13 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $245.61 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $168.34 | 5 | $0 (2024) |
| Axonics, Inc. | $162.66 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,954 | 85 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($377.43) |
| 2023 | $1,599 | 97 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($421.69) |
| 2022 | $1,409 | 94 | ABBVIE INC. ($359.76) |
| 2021 | $814.51 | 50 | AbbVie Inc. ($224.50) |
| 2020 | $431.00 | 31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($217.71) |
| 2019 | $466.23 | 21 | AbbVie, Inc. ($131.01) |
| 2018 | $380.77 | 16 | AbbVie, Inc. ($234.73) |
| 2017 | $421.25 | 16 | AbbVie, Inc. ($248.60) |
All Payment Transactions
410 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.51 | General |
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $91.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.19 | General |
| 10/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $72.78 | General |
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $162.66 | General |
| Category: Urology | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 916 | 1,578 | $517,455 | $102,392 |
| 2022 | 16 | 1,143 | 2,013 | $669,624 | $130,792 |
| 2021 | 17 | 1,305 | 2,424 | $818,215 | $178,414 |
| 2020 | 18 | 1,137 | 2,346 | $1.0M | $192,765 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 231 | $85,218 | $20,412 | 24.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 93 | 94 | $83,072 | $14,883 | 17.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 109 | 478 | $41,562 | $12,262 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $41,857 | $9,489 | 22.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 45 | 144 | $31,910 | $9,369 | 29.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 45 | 138 | $24,636 | $7,273 | 29.5% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 25 | 26 | $24,997 | $6,878 | 27.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 117 | 118 | $82,146 | $5,368 | 6.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 81 | 81 | $27,063 | $5,281 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 86 | $21,868 | $5,199 | 23.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 68 | 69 | $32,724 | $4,119 | 12.6% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 15 | 15 | $10,208 | $1,667 | 16.3% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $10,195 | $191.81 | 1.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 262 | $96,654 | $23,030 | 23.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 268 | $65,936 | $14,462 | 21.9% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2022 | 50 | 50 | $48,071 | $12,785 | 26.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 92 | 430 | $37,389 | $11,169 | 29.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 40 | 126 | $27,922 | $8,368 | 30.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 129 | 129 | $43,100 | $7,923 | 18.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 69 | 69 | $60,978 | $7,399 | 12.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $32,669 | $7,189 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 100 | 118 | $30,005 | $6,801 | 22.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 40 | 127 | $22,672 | $6,709 | 29.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 107 | 108 | $75,184 | $6,123 | 8.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 57 | $26,705 | $5,817 | 21.8% |
About Dr. Pragnesh Patel, MD
Dr. Pragnesh Patel, MD is a Gastroenterology healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1265787360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pragnesh Patel, MD has received a total of $7,476 in payments from pharmaceutical and medical device companies, with $1,954 received in 2024. These payments were reported across 410 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($7,237).
As a Medicare-enrolled provider, Patel has provided services to 4,501 Medicare beneficiaries, totaling 8,361 services with total Medicare billing of $604,363. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Sugar Land, TX
- Active Since 07/16/2012
- Last Updated 05/12/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1265787360
Products in Payments
- XIFAXAN (Drug) $1,089
- Humira (Biological) $458.45
- ZEPOSIA (Drug) $453.11
- TRULANCE (Drug) $422.86
- DUPIXENT (Biological) $380.78
- MAVYRET (Drug) $361.65
- Linzess (Drug) $245.61
- LINZESS (Drug) $204.81
- GATTEX (Drug) $185.94
- SUTAB (Drug) $175.76
- Entyvio (Biological) $165.87
- Axonics (Device) $162.66
- CREON (Drug) $150.13
- IBSRELA (Drug) $140.48
- DUOPA (Drug) $133.54
- VIBERZI (Drug) $101.61
- REMICADE (Biological) $99.95
- Gamunex-C (Biological) $98.97
- Talicia (Drug) $92.34
- RINVOQ (Biological) $89.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Sugar Land
Dr. Charles Phan, M.d, M.D
Gastroenterology — Payments: $220,102
Robert Davis, M.d, M.D
Gastroenterology — Payments: $10,999
Dr. Leka Gajula, Md, MD
Gastroenterology — Payments: $10,235
J Trabanino, M.d, M.D
Gastroenterology — Payments: $7,085
Dr. Stanley Stein, M.d, M.D
Gastroenterology — Payments: $6,633
Dr. Ephraim Nsien, Md, MD
Gastroenterology — Payments: $4,662